Cell Therapy – What Does It Take To Become a Mainstream Option
While cell therapies are still a small segment of therapeutics, the landscape is rapidly changing — with over 1,000 ongoing clinical trials and...
Blog
Read on
On Demand Webinar: Establishing a Stage-Gate Approach to Biomanufacturing
The need for advanced technology platforms that offer a clear, end-to-end path to commercial manufacturing is driving biotech companies to outsource...
Resilience Presenting at American Biomanufacturing Summit
Resilience is a proud to be participating in American Biomanufacturing Summit. The American Biomanufacturing Summit is one of the most senior-level...
Resilience Signs Multi-Year Strategic Biomanufacturing Partnership with Leading Pharmaceutical Company
SAN DIEGO, CA, February 16, 2023 – National Resilience, Inc. (Resilience), a technology-focused manufacturing company dedicated to broadening access...
Resilience is a Proud Sponsor of DCAT Week 2023
Resilience is a proud sponsor of DCAT Week 2023 in New York City. Join us March 20 – 23, 2023 for an exciting week of meetings, networking, and...
How Digital Twins are Shaping the Future of Continuous Bioprocessing with Resilience and Siemens
Resilience is thrilled to participate in a joint webinar, “How Digital Twins are Shaping the Future of Continuous Bioprocessing with Resilience and...
Alachua Biomanufacturing Expansion Video
We are remaking the way medicines are made and that starts with our facilities. At our Alachua, Florida campus, Building G defines the future of our...
Resilience Announces Equity Investment from Mubadala and Funding of New Biopharma Manufacturing Facility in the United Arab Emirates
SAN DIEGO--(BUSINESS WIRE)-- National Resilience, Inc. (Resilience), a technology-focused manufacturing company dedicated to broadening access to...